UBS’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

UBS’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$66.6M	Buy	725,782 +38,171	+6%	+$3.31M	0.05%	378
2014 Q2	$56.6M	Buy	687,611 +109,329	+19%	+$8.36M	0.04%	406
2014 Q1	$44.3M	Buy	578,282 +20,741	+4%	+$1.62M	0.04%	444
2013 Q4	$38.6M	Buy	557,541 +91,157	+20%	+$5.98M	0.04%	490
2013 Q3	$30.2M	Buy	466,384 +115,919	+33%	+$7.33M	0.03%	529
2013 Q2	$20.4M	Buy	+350,465	New	+$20M	0.02%	637

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RIG

RiverFront Investment Group Richmond, Virginia $6.46B AUM 18.45% 1-Year Est. Return

UBS's FBT Position: Q3 2014 in Review

UBS increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 5.6% in Q3 2014, buying an estimated $3.31M and bringing the position to 725,782 shares worth $66.6M. The position accounts for 0.05% of the portfolio, ranked #378.

UBS first reported a position in FBT in Q2 2013 and has held it in 6 quarters since. 98 funds tracked by Wall St. Rank hold FBT as of Q3 2014.

UBS held 725,782 shares of First Trust NYSE Arca Biotechnology Index Fund worth $66.6M as of Q3 2014.
UBS bought 38,171 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2014, an estimated $3.31M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of UBS's portfolio in Q3 2014, its #378 holding.
UBS first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 6 quarters since.
98 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.